Evidence map›Paper›PMID 32756484›Full record

ReviewInternational journal of molecular sciences2020

DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.

Fabian Caja, Ludmila Vodickova, Jan Kral, Veronika Vymetalkova, Alessio Naccarati, Pavel Vodicka

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Genetic Variation ofInternational journal of dentistry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The role of DNA mismatch repair in immunotherapy of human cancer.International journal of biological sciences · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Fabian CajaDepartment of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, 14200 Prague, Czech Republic.
Ludmila VodickovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic.
Jan KralDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic.
Veronika VymetalkovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic.ORCID 0000-0001-6870-6788
Alessio NaccaratiDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic.ORCID 0000-0001-5774-0905
Pavel VodickaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic.
Charles University · CZInstitute of Clinical and Experimental Medicine · CZItalian institute for Genomic Medicine · IT

Funding

Agentura Pro Zdravotnický Výzkum České Republiky NV18-00199Grantová Agentura České Republiky 18-09709S and 19-10543SInstitutional Grant RVO 61388971 (CZ)Ministerstvo Školství, Mládeže a Tělovýchovy (NPU I) Nr. LO1503Univerzita Karlova v Praze Progres Q28Univerzita Karlova v Praze UNCE/MED/006;
6 · The paper itself

Abstract

The phenotypic effects of single nucleotide polymorphisms (SNPs) in the development of sporadic solid cancers are still scarce. The aim of this review was to summarise and analyse published data on the associations between SNPs in mismatch repair genes and various cancers. The mismatch repair system plays a unique role in the control of the genetic integrity and it is often inactivated (germline and somatic mutations and hypermethylation) in cancer patients. Here, we focused on germline variants in mismatch repair genes and found the outcomes rather controversial: some SNPs are sometimes ascribed as protective, while other studies reported their pathological effects. Regarding the complexity of cancer as one disease, we attempted to ascertain if particular polymorphisms exert the effect in the same direction in the development and treatment of different malignancies, although it is still not straightforward to conclude whether polymorphisms always play a clear positive role or a negative one. Most recent and robust genome-wide studies suggest that risk of cancer is modulated by variants in mismatch repair genes, for example in colorectal cancer. Our study shows that rs1800734 in

Indexed as

Disease ProgressionDNA MethylationDNA Mismatch RepairGerm-Line MutationHumansMutL Protein Homolog 1MutS Homolog 2 ProteinNeoplasmsPolymorphism, Single NucleotideMLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 Proteincancergenesgenetic variantsgenotypemismatch repairpatientssingle nucleotide polymorphismtreatment outcome

Identifiers

PMID32756484
PMCPMC7432688
OpenAlexW3046315130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.